Alcon AG | ALC - Ebitda

Stock Price
61.40
Daily Change
0.92 1.52%
Monthly
-3.37%
Yearly
-26.75%
Q1 Forecast
60.90

Alcon AG reported $654M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 1.51B 1.28B Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 931.26M 60.26M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.03B 334M Jun/2025